KFC
BSX icon

Klingenstein Fields & Co’s Boston Scientific BSX Stock Holding History

Klingenstein Fields & Co’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.51M Buy
176,006
+334
+0.2% +$18.1K 0.26% 67
2026
Q1 		$11M Buy
+175,672
New +$14.1M 0.43% 57

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Klingenstein Fields & Co's BSX Position: Q2 2026 in Review

Klingenstein Fields & Co increased its Boston Scientific (BSX) stake by 0.19% in Q2 2026, buying an estimated $18.1K and bringing the position to 176,006 shares worth $7.51M. The position accounts for 0.26% of the portfolio, ranked #67.

Klingenstein Fields & Co first reported a position in BSX in Q1 2026 and has held it in 2 quarters since. The position peaked at $11M in Q1 2026. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Klingenstein Fields & Co held 176,006 shares of Boston Scientific worth $7.51M as of Q2 2026.
  • Klingenstein Fields & Co bought 334 Boston Scientific shares in Q2 2026, an estimated $18.1K.
  • Boston Scientific made up 0.26% of Klingenstein Fields & Co's portfolio in Q2 2026, its #67 holding.
  • Klingenstein Fields & Co first reported a position in Boston Scientific in Q1 2026 and has held it in 2 quarters since.
  • Klingenstein Fields & Co's Boston Scientific position peaked at $11M in Q1 2026.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Klingenstein Fields & Co's 13F filing for Q2 2026, filed 5 Aug 2026.